Author
Harvard UniversityORCID 0009-0003-1085-7817Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Joaquim Bellmunt B, Yingtian Xie, Miguel Gómez Muñoz…·Henry W. Long
This study identifies a tumor-cell MHC-II program linked to immunotherapy outcomes in bladder cancer across different stages and treatment settings.
Filipe L.F. Carvalho, Ji‐Hyun Lee, Nikolaos Kalavros…·Eliezer M. Van Allen
This study identifies tumor-myeloid crosstalk as a driver of cisplatin resistance in bladder cancer and proposes PARP14 inhibition as a therapeutic strategy.
Joaquim Bellmunt B, Yingtian Xie, Nuria Juanpere-Rodero…·Paloma Cejas
This study identifies epigenetic subtypes of high-grade T1 bladder cancer using integrated chromatin and transcriptomic data, revealing intra-tumor heterogeneity and distinct tumor microenvironment interactions.
Gunsagar Singh Gulati, Damien Vasseur, Rashad Nawfal…·Matthew L. Freedman
APEX infers cancer gene expression from plasma cfChIP-seq data, outperforming existing methods and enabling subtype classification and biomarker identification.